These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22171072)

  • 41. Pemetrexed combined with paclitaxel in patients with advanced or metastatic non-small-cell lung cancer: a phase I-II trial.
    Stathopoulos GP; Dimitroulis J; Toubis M; Katis C; Karaindros D; Stathopoulos J; Koutandos J
    Lung Cancer; 2007 Jul; 57(1):66-71. PubMed ID: 17382431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in human non-small cell lung cancer cells.
    Li T; Ling YH; Goldman ID; Perez-Soler R
    Clin Cancer Res; 2007 Jun; 13(11):3413-22. PubMed ID: 17545550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced folate carrier independent internalization of PEGylated pemetrexed: a potential nanomedicinal approach for breast cancer therapy.
    Vandana M; Sahoo SK
    Mol Pharm; 2012 Oct; 9(10):2828-43. PubMed ID: 22894559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term and low-grade safety results of a phase III study (PARAMOUNT): maintenance pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.
    Pujol JL; Paz-Ares L; de Marinis F; Dediu M; Thomas M; Bidoli P; Corral J; San Antonio B; Chouaki N; John W; Zimmermann A; Visseren-Grul C; Gridelli C
    Clin Lung Cancer; 2014 Nov; 15(6):418-25. PubMed ID: 25104617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness and safety of pemetrexed versus docetaxel as a treatment for advanced non-small cell lung cancer: a systematic review and meta-analysis.
    Di BS; Wei KP; Tian JH; Xiao XJ; Li Y; Zhang XH; Yu Q; Yang KH; Ge L; Huang WH; Zhang FW
    Asian Pac J Cancer Prev; 2014; 15(8):3419-24. PubMed ID: 24870732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Caffeine markedly sensitizes human mesothelioma cell lines to pemetrexed.
    Min SH; Goldman ID; Zhao R
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):819-27. PubMed ID: 17594092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pemetrexed combined with cisplatin or carboplatin regimen in the treatment of advanced recurrent or metastasis non-small cell lung cancer: analysis of 63 cases].
    Wang W; Shang L; Li X; Li J; Wen F; Liu J
    Zhongguo Fei Ai Za Zhi; 2011 Jan; 14(1):54-7. PubMed ID: 21219833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pemetrexed as second-line treatment in malignant pleural mesothelioma after platinum-based first-line treatment.
    Sørensen JB; Sundstrøm S; Perell K; Thielsen AK
    J Thorac Oncol; 2007 Feb; 2(2):147-52. PubMed ID: 17410031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program.
    Taylor P; Castagneto B; Dark G; Marangolo M; Scagliotti GV; van Klaveren RJ; Labianca R; Serke M; Schuette W; van Meerbeeck JP; Heigener D; Liu Y; Adachi S; Blatter J; von Pawel J
    J Thorac Oncol; 2008 Jul; 3(7):764-71. PubMed ID: 18594323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pemetrexed disodium.
    Gibbs D; Jackman A
    Nat Rev Drug Discov; 2005 May; Suppl():S16-7. PubMed ID: 15962527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors.
    Infante JR; Novello S; Ma WW; Dy GK; Bendell JC; Huff A; Wang Q; Suttle AB; Allen R; Xu CF; Ottesen LH; Burris HA; Adjei AA
    Invest New Drugs; 2013 Aug; 31(4):927-36. PubMed ID: 23179337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pemetrexed maintenance therapy in patients with malignant pleural mesothelioma.
    van den Bogaert DP; Pouw EM; van Wijhe G; Vernhout RM; Surmont VF; Hoogsteden HC; van Klaveren RJ
    J Thorac Oncol; 2006 Jan; 1(1):25-30. PubMed ID: 17409823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study.
    Ciuleanu T; Brodowicz T; Zielinski C; Kim JH; Krzakowski M; Laack E; Wu YL; Bover I; Begbie S; Tzekova V; Cucevic B; Pereira JR; Yang SH; Madhavan J; Sugarman KP; Peterson P; John WJ; Krejcy K; Belani CP
    Lancet; 2009 Oct; 374(9699):1432-40. PubMed ID: 19767093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
    Iwahori K; Serada S; Fujimoto M; Ripley B; Nomura S; Mizuguchi H; Shimada K; Takahashi T; Kawase I; Kishimoto T; Naka T
    Int J Cancer; 2013 Jan; 132(2):459-71. PubMed ID: 22532243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of radiation and pemetrexed on a human malignant mesothelioma cell line in vitro.
    Yoshida D; Ebara T; Sato Y; Kaminuma T; Takahashi T; Asao T; Nakano T
    Anticancer Res; 2011 Sep; 31(9):2847-51. PubMed ID: 21868528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase I trials of pemetrexed.
    Fossella FV; Gatzemeier U
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):8-16. PubMed ID: 12023787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase I study of carboplatin combined with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer.
    Takeoka H; Yamada K; Azuma K; Zaizen Y; Yamashita F; Yoshida T; Naito Y; Okayama Y; Miyamoto M; Hoshino T
    Jpn J Clin Oncol; 2014 May; 44(5):472-8. PubMed ID: 24688087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pemetrexed].
    Sudoh J; Gemma A
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):1033-8. PubMed ID: 18633241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Update of pemetrexed in thoracic oncology].
    Brechot JM; Morère JF
    Bull Cancer; 2007; 94 Spec No Actualites():S139-41. PubMed ID: 17845984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.